Cell Barcoding for High-Throughput Drug Screening
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current secondary screening assays for drug discovery are inefficient in distinguishing between different cell types and require large amounts of sample, making it costly and resource-intensive to profile cellular responses across multiple cell lines, especially in cancer therapeutics where diversity of cellular phenotypes complicates the identification of effective drug candidates.
Innovation Solution
A method employing multiple signal markers, with at least one being genetically encoded, to barcode cells, allowing for the identification of 6 or more different cell types per sample, enabling the detection of cellular responses to stimuli with high specificity and efficiency using flow cytometry or mass spectrometry.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Measurement precision
If traditional secondary screening assays are used to profile cellular responses across multiple cell lines, then comprehensive data on biological activity and cellular toxicity can be obtained, but the cost and sample requirements increase significantly
Solution Approach 1:
The patent combines multiple cell lines expressing different fluorescent protein markers into a single mixed population. This allows simultaneous analysis of multiple cell types in one assay, reducing the total sample volume required while maintaining comprehensive profiling capability across diverse cell lines
Solution Approach 2:
The invention creates a universal cell barcoding system using fluorescent protein markers that can identify and distinguish multiple cell types simultaneously. This multi-functional approach enables a single assay to provide comprehensive data on biological activity, cellular toxicity, and cell-type-specific responses without requiring separate assays for each cell line
2Reliability
If multiple cell lines are tested separately to account for cellular diversity in cancer therapeutics, then accurate identification of effective drug candidates is achieved, but the screening process becomes time-consuming and resource-intensive
Solution Approach 1:
The patent merges multiple cell lines into a single mixed population for simultaneous screening. Each cell line expresses unique fluorescent protein combinations serving as barcodes, enabling parallel analysis of drug responses across diverse cell types in one experiment, thereby reducing screening time while maintaining reliability
Solution Approach 2:
The invention uses fluorescent protein markers that emit different colors or fluorescence intensities to distinguish between cell lines. This color-based barcoding system allows rapid identification and quantification of cell-type-specific drug responses using flow cytometry or imaging, significantly accelerating the screening process without compromising accuracy
3Device complexity
If conventional screening methods are used to analyze single cell type and single parameter, then the assay design is simple, but sufficient information is not provided to make decisions on which compounds to move forward
Solution Approach 1:
The patent implements a multi-functional assay design where a single screening experiment simultaneously measures multiple parameters (biological activity, cellular toxicity, cell proliferation) across multiple cell types. The fluorescent barcoding system enables this expanded information gathering without proportionally increasing assay complexity, as the same basic workflow is used regardless of the number of cell lines or parameters measured
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
This approach reduces the cost and sample requirements while providing rich, informative data on cellular responses, enabling robust screening of drug candidates across diverse cell types with high confidence in results, thereby accelerating drug discovery.
Implementation Method 1
enabling the detection of cellular responses to stimuli with high specificity and efficiency using flow cytometry or mass spectrometry
Implementation Method 2
enabling the detection of cellular responses to stimuli with high specificity and efficiency using flow cytometry or mass spectrometry
Data Source
AI summary
Mixtures of cell types can be analyzed by having at least two signal markers, with at least one at three different levels to provide a barcode for each cell type. The mixture of cells may be subjected to a common candidate moiety and the effect of the moiety on the cells determined along with identification of the cell by the barcode. Conveniently, surface marker proteins and labeled antibodies can be used to create the barcode and the cells analyzed with flow cytometry.